ROBIN DAVISSON was named president and CEO-elect of the Melanoma Research Alliance effective Oct. 1.
The NCI Bypass Budget for 2017 asks for a 7-percent increase over fiscal 2016, followed by a series of annual 7-percent increases that would continue through 2026, when the institute's budget would double.
BROAD INSTITUTE and MD ANDERSON CANCER CENTER were designated the Genome Characterization Centers in a five-year project supported by the NCI to characterize the genomic changes found in tumors.
NIH, NCI and FDA should receive budget increases of at least 7 percent a year, the 2015 Cancer Progress Report by the American Association for Cancer Research recommends.
Gianni Bonadonna, 81, a pioneering cancer researcher whose work focused on Hodgkin's lymphoma and breast cancer, died Sept. 7.
LOIS TRAVIS was named the Lawrence H. Einhorn Professor of Cancer Research at the Indiana University School of Medicine and director of the Cancer Survivorship Research Program at the IU Melvin and Bren Simon Cancer Center.
Jeffrey and W. Kimryn Rathmell appointed to leadership roles at Vanderbilt University Medical Center
JEFFREY RATHMELL and W. KIMRYN RATHMELL were both appointed to leadership roles at Vanderbilt University Medical Center.
MASSIMO CRISTOFANILLI was appointed associate director for precision medicine and translational research at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and director of Northwestern OncoSET.
FRANCIS COLLINS, director of the NIH, was awarded the Leadership in Personalized Medicine Award by the Personalized Medicine Coalition. He will be presented the award during the Personalized Medicine Conference at Harvard Medical School Nov. 19.
ROBERT DIPAOLA, STEPHEN GRUBER and CANDACE JOHNSON were elected to the board of directors of the Association of American Cancer Institutes. Their three-year terms will begin Oct. 25, during the annual meeting of the AACI and the Cancer Center Administrators Forum in Washington, D.C.
